Young Children with Mild to Severe Hearing Loss (R21)
The summary for the Young Children with Mild to Severe Hearing Loss (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Young Children with Mild to Severe Hearing Loss (R21): -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD) encourages research applications from institutions/organizations addressing research needs on the young child (infants and children) with mild to severe hearing loss. Development, refinement or modification of measurement tools for young children is also encouraged.. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-07-399, that encourages applications under the NIH Research Project Grant (R01). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: | Young Children with Mild to Severe Hearing Loss (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-07-400 |
Type of Funding: | Grant |
CFDA Numbers: | 93.173 |
CFDA Descriptions: | Research Related to Deafness and Communication Disorders |
Current Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Jul 13, 2007 |
Creation Date: | Dec 05, 2008 |
Archive Date: | Nov 16, 2010 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...
- • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...
- • BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
- • BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Mo...
- • BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technolo...
- • NIDCD Patient-Oriented Research Grant (R21)
- • Cell Lineage and Developmental Studies in Hearing and Balance
- • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)